Clinical Trial Update: [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluates the PET imaging agent [18F]Florastamin for detecting suspected recurrent or metastatic prostate cancer; FutureChem is the sponsor a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-Florastamin (Fluorine-18 Florastamin)

Snippet

Sponsor: FutureChem | Conditions: High Risk Prostate Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING